- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04917146
Systemic Sclerosis' Relatives Reflex (RelativReflex)
"Family Caregiver Reflex": Family Support for Patients Followed for Systemic Sclerosis - Pilot Study Evaluating the Experience and Role of Family Caregivers in Order to Identify and Include Them in Therapeutic Educational Programs
Systemic sclerosis (SSc) is a rare, serious disease that is part of chronic inflammatory rheumatism.
It requires multidisciplinary care and a specific therapeutic patient education program.
SSc actually affects every member of the family, the patient as well as those close to him. It deeply affects each member of the family (increased fatigue, stress, social isolation, exhaustion, financial difficulties …) which gives rise to threats of vulnerability and modulates the balance of family relations.
However, there are very few studies on family SSc caregivers. We have raised the question about the experience and needs of caregivers in order to better support them.
The main purpose of this pilot study is to better understand the particularities of relatives (caregivers) of patients suffering from systemic sclerosis and will allow us to refine our knowledge about the assistance they provide for SSc patients and its impact on family caregivers :
- lived experience of the relatives (caregivers);
- physical, mental and socio-professional health of the relatives (caregiver);
- relationship between the relative (caregiver) and the patient.
The research will be carried out at Cochin Hospital, in collaboration with the French Scleroderma Association (ASF).
It will be offered to relatives of SSc patients identified by health team in the rheumatology or internal medicine department, as well as during consultations and patient education activities.
An information note and an informed consent will be given to each patient and his caregiver ; Self-questionnaires will then be offered to relatives.
They can fill them out while they are in the hospital, or at home and return the completed questionnaire.
Caregivers will be questioned about their quality of life, health, relationship with the patient and support situation.
They will also be asked for personal socio-demographic information concerning the patient.
The "caregiver reflex" project is part of the 2020-2022 mobilization and support strategy for caregivers "acting for the health of family caregivers", in which the establishment of a "caregiver reflex" among professionals health is put forward.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Exploratory study with family caregivers of patients suffering from Systemic Sclerosis (SSc).
This research work will allow to better understand the experiences and needs of these very particular caregivers, in order to offer them specific educational support and workshops.
It should also allow healthcare teams to develop a "family caregiver reflex", especially in the context of SSc disease to identify and include PAs in PTE programs.
Primary objectives:
Identify caregivers in the SCS patient's family circle: in order to analyze their profile and assess their needs, expectations, projects and difficulties:
- Identify who are the caregivers of SSc people: epidemiological data, profiles of SSc patients followed in rheumatology and Internal medicine departments of Cochin hospital (sex, age, professional activity, possible presence of young people in the entourage, etc.);
- assess the assistance provided by the caregivers: type and specificity;
- Specify the experience and feelings of the caregivers in relation to this aid (positive or negative impact)
- Identify fragile-vulnerable caregivers .
Secondary objectives:
Develop, from this data, educational tools to share with the other members of the FSMR FAI2R and specifically dedicated to the caregivers of SSc patients:
- "Caregiver reflex" tool intended for professionals to better identify and identify caregivers of SSc patients;
- Specific interview guide for the educational diagnosis of caregivers;
- Examples of educational workshops for caregivers meeting identified needs (workshop experienced by the illness of the other, stress management, fatigue, dietary advice, lifestyle, to assist persons in administrative and social procedures...)
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Paris, France, 75014
- Rhumatology Service
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Participants:
relatives of patients suffering from Systemic Scleroderma
Two possible inclusion methods:
- At the hospital, via health professionals (doctor, nurse, social worker, etc.) who identify the loved one accompanying the patient during a consultation or hospitalization;
- Via the French Scleroderma Association - ASF (call for participation)
They will be presented with the study by the recruiting psychologist or education nurse and given an information note and consent to participate. Patients will also be presented with an information letter and consent to participate .
Description
Inclusion Criteria:
- Relatives caregivers of patients suffering from Systemic Scleroderma (family, friends, neighbours);
- Be at least 18 years old;
- Not being the patient's professional caregiver;
- Have signed the informed consent to participate.
Exclusion Criteria:
- Inability to answer questionnaires (language, cognitive disorders, etc.).
- under curatorship or tutorship
- with State medical care (AME)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Caregivers (CG)
Caregivers of patients with systemic Scleroderma
|
Sociodemographic and medical information for the patient and the CG. SF36 questionnaire for the quality of life (physical, mental) of family CGs This assessment will be supplemented by specific questions relating to: physical health, emotional state, personal and leisure activities of the caregiver. The CG's knowledge and representations of the disease : questions adapted from the Brief-IPQ disease representation questionnaire. Questions will also focus on the caregiver's reactions to the patient's illness. We have constructed a questionnaire to assess the main areas of aid in the context of SSc: emotional, domestic help, administrative, medical, for trave (16 items and an open question). The CG Reaction Assessment-CRA questionnaire to assess the positive and negative dimensions of helping (24 items). It assesses five dimensions: self-esteem, financial impact, impact on health, impact on time and lack of family support. The reason for the assistance provided. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Questionnaire
Time Frame: Inclusion visit 1 day
|
Sociodemographic and medical information concerning the patient assisted Patients' sociodemographic and medical information will be collected: age, gender, family composition, family relationship with the family caregiver, length of the illness.
|
Inclusion visit 1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Questionnaire
Time Frame: Inclusion visit 1 day
|
Socio-demographic information about the caregiver Sociodemographic information will be collected on the informal caregiver: age, sex, professional situation, seniority of the help.
|
Inclusion visit 1 day
|
|
Questionnaire SF36
Time Frame: Inclusion visit 1 day
|
Physical and mental health The SF36 questionnaire (Leplège et al., 1998) will be used to assess the quality of life of family caregivers. This widely used questionnaire is divided on 6 items assessing the physical and mental quality of life. This assessment will be supplemented by specific questions relating to:
|
Inclusion visit 1 day
|
|
Questionnaire
Time Frame: Inclusion visit 1 day
|
The relationship with the patient The caregiver's knowledge and representations of the disease will be assessed using questions adapted from the Brief-IPQ disease representation questionnaire (Broadbent et al., 2006). Questions will also focus on the caregiver's reactions to the patient's illness. |
Inclusion visit 1 day
|
|
Questionnaire
Time Frame: Inclusion visit 1 day
|
Aid activities To date, there is no questionnaire to assess the aid activity in the context of chronic inflammatory rheumatism.
The existing questionnaires on the subject being too often linked to situations of significant dependence, as in the context of neurodegenerative diseases, we have constructed a questionnaire to assess the main areas of aid in the context of SSc: emotional, domestic help , administrative, medical, for travel.
It is composed of 16 items and an open question.
|
Inclusion visit 1 day
|
|
Questionnaire
Time Frame: Inclusion visit 1 day
|
Positive and negative dimensions of aid The Caregiver Reaction Assessment-CRA questionnaire (Given et al., 1992) will be used to assess the positive and negative dimensions of helping. This questionnaire has 24 items. It assesses five dimensions: self-esteem, financial impact, impact on health, impact on time and lack of family support. Finally, two questions are asked to assess the reason for the assistance provided. |
Inclusion visit 1 day
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Janine-Sophie Giraudet-Le Quintrec, MD, Cochin Hospital - APHP
Publications and helpful links
General Publications
- Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res. 2006 Jun;60(6):631-7. doi: 10.1016/j.jpsychores.2005.10.020.
- Leplege A, Ecosse E, Verdier A, Perneger TV. The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol. 1998 Nov;51(11):1013-23. doi: 10.1016/s0895-4356(98)00093-6.
- Given CW, Given B, Stommel M, Collins C, King S, Franklin S. The caregiver reaction assessment (CRA) for caregivers to persons with chronic physical and mental impairments. Res Nurs Health. 1992 Aug;15(4):271-83. doi: 10.1002/nur.4770150406.
- Brignon M, Vioulac C, Boujut E, Delannoy C, Beauvais C, Kivits J, Poivret D, Giraudet Le Quintrec JS, Untas A, Rat AC. Patients and relatives coping with inflammatory arthritis: Care teamwork. Health Expect. 2020 Feb;23(1):137-147. doi: 10.1111/hex.12982. Epub 2019 Nov 27.
- Brouwer WB, van Exel NJ, van de Berg B, Dinant HJ, Koopmanschap MA, van den Bos GA. Burden of caregiving: evidence of objective burden, subjective burden, and quality of life impacts on informal caregivers of patients with rheumatoid arthritis. Arthritis Rheum. 2004 Aug 15;51(4):570-7. doi: 10.1002/art.20528.
- Canedo-Ayala M, Rice DB, Levis B, Carrier ME, Cumin J, Malcarne VL, Hagedoorn M, Thombs BD; Scleroderma Caregiver Advisory Committee. Factors associated with symptoms of depression among informal caregivers of people with systemic sclerosis: a cross-sectional study. Disabil Rehabil. 2020 Feb;42(3):394-399. doi: 10.1080/09638288.2018.1500647. Epub 2018 Aug 19.
- Jacobi CE, van den Berg B, Boshuizen HC, Rupp I, Dinant HJ, van den Bos GA. Dimension-specific burden of caregiving among partners of rheumatoid arthritis patients. Rheumatology (Oxford). 2003 Oct;42(10):1226-33. doi: 10.1093/rheumatology/keg366. Epub 2003 Jun 16.
- Kasle S, Wilhelm MS, Zautra AJ. Rheumatoid arthritis patients' perceptions of mutuality in conversations with spouses/partners and their links with psychological and physical health. Arthritis Rheum. 2008 Jul 15;59(7):921-8. doi: 10.1002/art.23821.
- Lam M, Lehman AJ, Puterman E, DeLongis A. Spouse depression and disease course among persons with rheumatoid arthritis. Arthritis Rheum. 2009 Aug 15;61(8):1011-7. doi: 10.1002/art.24510.
- Matheson L, Harcourt D, Hewlett S. 'Your whole life, your whole world, it changes': partners' experiences of living with rheumatoid arthritis. Musculoskeletal Care. 2010 Mar;8(1):46-54. doi: 10.1002/msc.165.
- Rice DB, Canedo-Ayala M, Carboni-Jimenez A, Carrier ME, Cumin J, Malcarne VL, Hagedoorn M, Thombs BD; Scleroderma Caregiver Advisory Team. Challenges and support service preferences of informal caregivers of people with systemic sclerosis: a cross-sectional survey. Disabil Rehabil. 2020 Aug;42(16):2304-2310. doi: 10.1080/09638288.2018.1557268. Epub 2019 Jan 29.
- Untas A, Vioulac C, Boujut E, Delannoy C, Poivret D, Rat AC, Beauvais C, Giraudet Le Quintrec JS. What Is Relatives' Role in Arthritis Management? A Qualitative Study of the Perceptions of Patient-Relative Dyads. Patient Prefer Adherence. 2020 Jan 7;14:45-53. doi: 10.2147/PPA.S231919. eCollection 2020.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- APHP210756
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Systemic Sclerosis
-
AmgenTerminatedDiffuse Cutaneous Systemic Sclerosis | Sclerosis, SystemicSpain, Japan, Romania, United States, Mexico, Argentina, Israel, Greece, Chile, Serbia, South Korea, Italy, Poland, Portugal, United Kingdom
-
Beijing GoBroad HospitalCARsgen Therapeutics Co., Ltd.RecruitingSystemic Lupus Erythematosus (SLE) | Systemic Sclerosis (SSc)China
-
AmgenTerminatedDiffuse Cutaneous Systemic Sclerosis | Sclerosis, SystemicSpain, Serbia
-
Michael M. PhamTerminatedSystemic Sclerosis | Scleroderma, Systemic | Scleroderma, Diffuse | Diffuse Cutaneous Systemic Sclerosis | Interstitial Lung Disease | Scleroderma | Systemic Sclerosis, Diffuse | Diffuse Systemic Sclerosis | Pulmonary Fibrosis Interstitial | Diffuse Scleroderma | Diffuse Cutaneous Scleroderma | Progressive Systemic... and other conditionsUnited States
-
argenxRecruitingSystemic Sclerosis (SSc)Croatia, Spain, Denmark, Italy, Germany, Lithuania, United Kingdom, Netherlands, Poland, Belgium, United States, Switzerland, Mexico, Argentina, France, Bulgaria, Chile, Greece, Serbia, Portugal, Puerto Rico, Czechia, Romania, Hungary
-
University of ManchesterCompletedEarly Diffuse Cutaneous Systemic Sclerosis
-
Fred Hutchinson Cancer CenterNational Institute of Allergy and Infectious Diseases (NIAID)CompletedSystemic Scleroderma | Severe Systemic SclerosisUnited States
-
Kadmon, a Sanofi CompanyTerminatedDiffuse Cutaneous Systemic Sclerosis | System; SclerosisUnited States
-
The Children's Hospital of Zhejiang University...Guangzhou Women and Children's Medical CenterRecruitingSystemic Sclerosis (SSc)China, Christmas Island
-
University of PatrasRecruitingSSc-Systemic SclerosisGreece
Clinical Trials on Self-administered questionnaires for relatives (caregivers=CG)
-
Hospices Civils de LyonNot yet recruitingDiffuse Large B-cell Lymphoma (DLBCL) | CAR-T Cells TreatmentFrance
-
University Hospital, LilleCompletedBreast Cancer | Breast Neoplasms | Breast Carcinoma | Breast TumorFrance
-
Central Hospital, Nancy, FranceCompleted
-
University Hospital, BordeauxCompletedSkin Cancer Face | Surgical IncisionFrance
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinWithdrawn
-
Columbia UniversityEnrolling by invitationSuicide | Suicide Attempt | Suicide Ideation | Adolescent SuicidalityUnited States
-
Duke UniversityNational Institute of Nursing Research (NINR)Completed
-
Kourosh NajafiNot yet recruitingNonspecific Chronic Low Back Pain
-
Centre Hospitalier Universitaire DijonCompleted
-
ANRS, Emerging Infectious DiseasesRecruiting